Complementing these tools, cognitive assessments such as the Mini-Mental State Examination (MMSE) and Trail Making Test, when paired with IGF-I monitoring, support diagnosis and prognosis, with higher IGF-I levels linked to improved executive function in mild cognitive impairment (MCI) [80,137,138]. The gene discussed is IGF1; the disease is Cognitive impairment.